Table 1 Univariate analysis of COL5A1 expression and clinical parameters in gliomas.
Univariate analysis | |||
|---|---|---|---|
Variable | Hazard ratio | 95% confidence interval | p value |
Sex (male/female) | 1.077 | 0.594–1.953 | 0.806 |
Age (<65/≥65) | 2.626 | 1.110–6.216 | 0.028* |
IDH1 R132H (negative/positive) | 1.000 | 0.647–1.547 | 0.999 |
ATRX (preserved/lost) | 0.771 | 0.428–1.387 | 0.385 |
H3 K27M (negative/positive) | 1.084 | 0.747–1.572 | 0.671 |
MGMT (preserved/lost) | 0.816 | 0.426–1.565 | 0.541 |
EGFR (negative/positive) | 1.038 | 0.382–2.819 | 0.942 |
EGFRvIII (negative/positive) | 1.138 | 0.807–1.604 | 0.462 |
P53 (negative/overexpressed) | 1.576 | 1.118–2.220 | 0.009* |
Neurofilament (negative/positive) | 1.296 | 0.805–2.087 | 0.286 |
NF1 (negative/positive) | 0.938 | 0.697–1.263 | 0.673 |
PDGFRA (negative/positive) | 2.054 | 1.117–3.777 | 0.021* |
COL5A1(negative/positive) | 1.487 | 0.792–2.792 | 0.218 |